Japan· JP-6343441D6020
エフトレノナコグ アルファ（遺伝子組換え）
A medicinal product containing エフトレノナコグ アルファ（遺伝子組換え）, registered in Japan by サノフィ, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- エフトレノナコグ アルファ（遺伝子組換え）
- Manufacturer
- サノフィ
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
エフトレノナコグ アルファ（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenALPROLIX 1000 IE Pulver och vätska till injektionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- BelgiumAlprolix 1000 IUSwedish Orphan Biovitrum (Publ)
- SwitzerlandAlprolix
- CzechiaALPROLIXSwedish Orphan Biovitrum AB (publ), Stockholm
- SpainALPROLIX 1.000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLESwedish Orphan Biovitrum Ab (Publ)
- FinlandALPROLIXSwedish Orphan Biovitrum AB (publ)
- FranceALPROLIX 1000 UI, poudre et solvant pour solution injectableSWEDISH ORPHAN BIOVITRUM (SUEDE)
- United KingdomAlprolix 1,000unit powder and solvent for solution for injection vialsSwedish Orphan Biovitrum Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Alprolix
- Liechtenstein · Alprolix
- Norway · Alprolix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4a189c2-abed-4303-8fe6-34809dadf860 GET /v1/drugs/e4a189c2-abed-4303-8fe6-34809dadf860?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "４，０００国際単位１瓶（溶解液付）",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "6343441D6020",
"category": "注射薬",
"price_yen": 778393,
"generic_name": "エフトレノナコグ アルファ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "6343",
"transitional_expiry": null
}See everything about エフトレノナコグ アルファ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.